動物用医薬品調合の世界市場レポート 2024年

動物用医薬品調合の市場規模は近年力強く成長しています。2023年の15億6,000万米ドルから2024年には16億9,000万米ドルへ、CAGR8.1％で成長すると予測されています。過去実績期間中に観察された成長は、動物用医薬品調合を管理する規制状況、獣医学分野での実践の進化、配合の利点に対する市場の意識の高まり、特定の動物の健康ニーズに対して利用可能な商業的選択肢の制限、獣医学コミュニティ内の協力関係の強化など、いくつかの要因に起因しています。これらの要因が総合的に、獣医業界における動物用医薬品調合の実績と採用に貢献しました。

2023年の動物用医薬品調合市場で最大の地域は北米でした。動物用医薬品調合市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 動物用医薬品調合市場の特徴

第3章 動物用医薬品調合市場の動向と戦略

第4章 動物用医薬品調合市場-マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の動物用医薬品調合市場の規模と成長

• 世界の動物用医薬品調合市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の動物用医薬品調合市場規模実績と成長、2018年～2023年
• 世界の動物用医薬品調合市場規模と成長予測、2023年～2028年、2033年

第6章 動物用医薬品調合市場セグメンテーション

• 世界の動物用医薬品調合市場、動物タイプ別のセグメンテーション、実績・予測、2018年～2023年、2023年～2028年、2033年
• コンパニオンアニマル
• 家畜
• 世界の動物用医薬品調合市場、製品別セグメンテーション、実績・予測、2018年～2023年、2023年～2028年、2033年
• 抗感染症薬
• 抗炎症剤
• ホルモンと代替品
• CNSエージェント
• その他の製品
• 世界の動物用医薬品調合市場、投与経路別セグメンテーション、実績・予測、2018年～2023年、2023年～2028年、2033年
• 経口
• 注射可能
• 局所
• その他の投与経路
• 世界の動物用医薬品調合市場、用途別セグメンテーション、実績・予測、2018年～2023年、2023年～2028年、2033年
• 動物病院
• 動物クリニック
• 動物用診断センター

第7章 動物用医薬品調合市場の地域および国分析

• 世界の動物用医薬品調合市場、地域別、実績・予測、2018年～2023年、2023年～2028年、2033年
• 世界の動物用医薬品調合市場、国別、実績・予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋の動物用医薬品調合市場

第9章 中国の動物用医薬品調合市場

第10章 インドの動物用医薬品調合市場

第11章 日本の動物用医薬品調合市場

第12章 オーストラリアの動物用医薬品調合市場

第13章 インドネシアの動物用医薬品調合市場

第14章 韓国の動物用医薬品調合市場

第15章 西欧の動物用医薬品調合市場

第16章 英国の動物用医薬品調合市場

第17章 ドイツの動物用医薬品調合市場

第18章 フランスの動物用医薬品調合市場

第19章 イタリアの動物用医薬品調合市場

第20章 スペインの動物用医薬品調合市場

第21章 東欧の動物用医薬品調合市場

第22章 ロシアの動物用医薬品調合市場

第23章 北米の動物用医薬品調合市場

第24章 米国の動物用医薬品調合市場

第25章 カナダの動物用医薬品調合市場

第26章 南米の動物用医薬品調合市場

第27章 ブラジルの動物用医薬品調合市場

第28章 中東の動物用医薬品調合市場

第29章 アフリカの動物用医薬品調合市場

第30章 動物用医薬品調合市場の競合情勢と企業プロファイル

• 動物用医薬品調合市場の競合情勢
• 動物用医薬品調合市場の企業プロファイル
  • Wedgewood Pharmacy LLC
  • Triangle Compounding Pharmacy Inc.
  • Davis Islands Pharmacy &Compounding Lab
  • Custom Med Compounding Pharmacy
  • Central Compounding Center South LLC

第31章 世界の動物用医薬品調合市場の競合ベンチマーキング

第32章 世界の動物用医薬品調合市場の競争ダッシュボード

第33章 動物用医薬品調合市場における主要な合併と買収

第34章 動物用医薬品調合市場の将来展望と可能性分析

第35章 付録

“Animal Drug Compounding Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal drug compounding market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for animal drug compounding? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The animal drug compounding market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Animal Type: Companion Animals; Livestock Animals
• 2) By Product: Anti-infective Agents; Anti-inflammatory Agents; Hormones And Substitutes; CNS Agents; Other Products
• 3) By Route of Administration: Oral; Injectable; Topical; Other Routes Of Administration
• 4) By Application: Veterinary Hospitals; Veterinary Clinics; Veterinary Diagnostic Centers
• Companies Mentioned: Wedgewood Pharmacy LLC; Triangle Compounding Pharmacy Inc.; Davis Islands Pharmacy & Compounding Lab; Custom Med Compounding Pharmacy; Central Compounding Center South LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Animal drug compounding involves the process of customizing and altering the ingredients of multiple medicines to create a personalized medication suitable for the specific needs of individual animals or groups of animals. This practice is crucial in veterinary medicine for providing tailored medical treatment to animals.

The primary products of animal drug compounding include anti-infective agents, anti-inflammatory agents, hormones and substitutes, central nervous system (CNS) agents, and other specialized products. Anti-infective agents encompass medications such as antibiotics, antivirals, and antifungals, used to prevent and treat various infections in animals. These agents play a vital role in eliminating infectious germs and controlling the spread of infections among animals. Animal drug compounding is applicable to various types of animals, including companion animals and livestock, and can be administered through different routes such as oral, injectable, topical, among others. This practice is commonly employed in veterinary hospitals, clinics, and diagnostic centers dedicated to veterinary care.

The animal drug compounding market research report is one of a series of new reports from The Business Research Company that provides animal drug compounding market statistics, including animal drug compounding industry global market size, regional shares, competitors with an animal drug compounding market share, detailed animal drug compounding market segments, market trends and opportunities, and any further data you may need to thrive in the animal drug compounding industry. This animal drug compounding market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal drug compounding market size has grown strongly in recent years. It will grow from $1.56 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth observed during the historical period can be attributed to several factors, including the regulatory landscape governing animal drug compounding, the evolving practices within the veterinary field, increased market awareness of the benefits of compounding, limited commercial options available for certain animal health needs, and enhanced collaboration within the veterinary community. These factors collectively contributed to the historical growth and adoption of animal drug compounding in the veterinary industry.

The animal drug compounding market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The anticipated growth in the forecast period can be attributed to various factors, including regulatory developments affecting animal drug compounding, evolving trends in pet ownership, the increasing demand for specialized veterinary care, the globalization of veterinary services, and advancements in veterinary medicine. Key trends expected in the forecast period encompass a heightened focus on flavoring and palatability of compounded medications, increased demand for specialized dosage forms, collaboration initiatives between veterinarians and compounding pharmacists, a focus on pain management solutions, and a growing role for animal drug compounding in veterinary hospice care. These trends collectively contribute to the continued expansion and importance of animal drug compounding in the field of veterinary medicine.

The upward trend in animal adoption rates is anticipated to drive the growth trajectory of the animal drug compounding market. Animal adoption involves acquiring animals through rescue groups rather than purchasing them from breeders or pet shops. Adopted animals often require specialized medications that aren't readily available in standard formulations due to pre-existing health conditions. This surge in adoption rates is fostering a demand for customized animal medications, thereby fueling the need for animal drug compounding services. For instance, Chewy, Inc. reported approximately 977,202 pets were adopted in the US in 2021, marking the highest adoption rate in six years. Additionally, a national survey by Animal Medicines Australia indicated a rise in Australian households owning dogs, increasing from 40% in 2019 to 48% in 2022. This surge in animal adoption rates signifies a significant driver behind the growth of the animal drug compounding market.

The surge in pet-related spending is poised to bolster the expansion of the animal drug compounding market. Pet expenditure encompasses the total amount spent on various pet-related expenses. This increase in spending encourages the demand for tailored medications tailored to individual animal needs. It incentivizes compounding pharmacies to provide specialized services in veterinary care. For instance, the American Pet Products Association reported total pet industry expenditures in the US reached $123.6 billion in 2023, witnessing a 19% increase from $103.6 billion in 2020. This surge in pet expenditure significantly contributes to the growth of the animal drug compounding market.

Key players within the animal drug compounding market are channeling investments into innovative technologies to drive market revenues. Evonik, a Germany-based specialty chemicals company, made a substantial investment in Revivo BioSystems in December 2021. Revivo BioSystems has developed organ-on-a-chip technology, utilizing a realistic 4D model of human skin for testing chemical, cosmetic, and pharmaceutical compounds. This investment aligns with Evonik's commitment to supporting advanced technologies that offer alternatives to conventional research methods, accelerating more sustainable and ethical practices. The innovative organ-on-a-chip technology provides a quicker, more reliable, and cost-efficient alternative to animal testing, signifying a significant advancement in the field.

Leading entities within the animal drug compounding market are actively engaging in partnerships to bolster their revenues and market positioning. Brava, a tech-driven network of compounding pharmacies, collaborates with veterinarians, offering innovative tools, expert pharmacy support, and exceptional customer care. In October 2022, Veterinary Growth Partners, a prominent US-based veterinary services organization representing over 6,000 veterinary practices, designated Brava as its preferred veterinary compounding pharmacy provider. This partnership strives to enhance personalized care in veterinary compounding, streamline processes to ensure regulatory compliance, and deliver top-notch compounding pharmacy solutions.

In April 2021, Partners Group, a Swiss-based private equity firm, completed the acquisition of Wedgewood Pharmacy for $700 million. This strategic acquisition was intended to augment the company's reach and service offerings within the animal health market. Wedgewood Pharmacy, a US-based company specializing in animal drug compounding, is a key player in delivering tailored pharmaceutical solutions for veterinary care. The acquisition aligns with Partners Group's objectives to broaden its presence and influence in the animal drug compounding sector, tapping into Wedgewood Pharmacy's expertise and market standing.

Major companies operating in the animal drug compounding market report are Wedgewood Pharmacy LLC, Triangle Compounding Pharmacy Inc., Davis Islands Pharmacy & Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South LLC, Wellness Compounding Pharmacy of Cary LLC, Miller's Pharmacy, Caringbah Compounding Pharmacy Pty. Ltd., Smith Drug and Compounding Inc., Specialist Compounding Pharmacy Pte Ltd., Tache Pharmacy & Medical Supplies, Hoye's Pharmacy, Vertisis Custom Pharmacy LLC, Smith-Caldwell Drug Store Inc., Sixth Avenue Medical Pharmacy, Pharmaca Integrative Pharmacy Inc., Akina Animal Health, Letco Medical LLC, The Pet Apothecary LLC, Vetsource Inc., Roadrunner Pharmacy, Medisca Inc., BCP Veterinary Pharmacy, VetRxDirect LLC, Diamondback Drugs, Vetcentric Pty. Ltd., Pet Health Pharmacy, PetMed Express Inc., PetRx2Go, South Wellness Pharmacy .

North America was the largest region in the animal drug compounding market in 2023. The regions covered in the animal drug compounding market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the animal drug compounding market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The animal drug compounding market consists of sales of flavored medications, suppositories, and ophthalmic preparations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Animal Drug Compounding Market Characteristics

3. Animal Drug Compounding Market Trends And Strategies

4. Animal Drug Compounding Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Animal Drug Compounding Market Size and Growth

• 5.1. Global Animal Drug Compounding Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Animal Drug Compounding Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Animal Drug Compounding Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Animal Drug Compounding Market Segmentation

• 6.1. Global Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Companion Animals
• Livestock Animals
• 6.2. Global Animal Drug Compounding Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Anti-infective Agents
• Anti-inflammatory Agents
• Hormones And Substitutes
• CNS Agents
• Other Products
• 6.3. Global Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Injectable
• Topical
• Other Routes Of Administration
• 6.4. Global Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Veterinary Diagnostic Centers

7. Animal Drug Compounding Market Regional And Country Analysis

• 7.1. Global Animal Drug Compounding Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Animal Drug Compounding Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Animal Drug Compounding Market

• 8.1. Asia-Pacific Animal Drug Compounding Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Animal Drug Compounding Market

• 9.1. China Animal Drug Compounding Market Overview
• 9.2. China Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Animal Drug Compounding Market

• 10.1. India Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Animal Drug Compounding Market

• 11.1. Japan Animal Drug Compounding Market Overview
• 11.2. Japan Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Animal Drug Compounding Market

• 12.1. Australia Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Animal Drug Compounding Market

• 13.1. Indonesia Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Animal Drug Compounding Market

• 14.1. South Korea Animal Drug Compounding Market Overview
• 14.2. South Korea Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Animal Drug Compounding Market

• 15.1. Western Europe Animal Drug Compounding Market Overview
• 15.2. Western Europe Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Animal Drug Compounding Market

• 16.1. UK Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Animal Drug Compounding Market

• 17.1. Germany Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Animal Drug Compounding Market

• 18.1. France Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Animal Drug Compounding Market

• 19.1. Italy Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Animal Drug Compounding Market

• 20.1. Spain Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Animal Drug Compounding Market

• 21.1. Eastern Europe Animal Drug Compounding Market Overview
• 21.2. Eastern Europe Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Animal Drug Compounding Market

• 22.1. Russia Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Animal Drug Compounding Market

• 23.1. North America Animal Drug Compounding Market Overview
• 23.2. North America Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Animal Drug Compounding Market

• 24.1. USA Animal Drug Compounding Market Overview
• 24.2. USA Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Animal Drug Compounding Market

• 25.1. Canada Animal Drug Compounding Market Overview
• 25.2. Canada Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Animal Drug Compounding Market

• 26.1. South America Animal Drug Compounding Market Overview
• 26.2. South America Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Animal Drug Compounding Market

• 27.1. Brazil Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Animal Drug Compounding Market

• 28.1. Middle East Animal Drug Compounding Market Overview
• 28.2. Middle East Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Animal Drug Compounding Market

• 29.1. Africa Animal Drug Compounding Market Overview
• 29.2. Africa Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Animal Drug Compounding Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Animal Drug Compounding Market Competitive Landscape And Company Profiles

• 30.1. Animal Drug Compounding Market Competitive Landscape
• 30.2. Animal Drug Compounding Market Company Profiles
  • 30.2.1. Wedgewood Pharmacy LLC
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Triangle Compounding Pharmacy Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Davis Islands Pharmacy & Compounding Lab
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Custom Med Compounding Pharmacy
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Central Compounding Center South LLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Animal Drug Compounding Market Competitive Benchmarking

32. Global Animal Drug Compounding Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Animal Drug Compounding Market

34. Animal Drug Compounding Market Future Outlook and Potential Analysis

• 34.1 Animal Drug Compounding Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Animal Drug Compounding Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Animal Drug Compounding Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer